Please enable JavaScript to continue using this application.

Compare $QTTB vs $TLSI | Chartloom

Compare

$QTTB vs $TLSI

Q32 Bio Inc · TriSalus Life Sciences Inc

QTTB

Q32 Bio Inc

TLSI

TriSalus Life Sciences Inc

Compare $QTTB vs $TLSI

Comparing Q32 Bio Inc and TriSalus Life Sciences Inc

QTTBQ32 Bio Inc

TLSITriSalus Life Sciences Inc

QTTBQ32 Bio Inc

Market cap

$248M

P/E (TTM)

8.22x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

142.4%

52W performance

178.9%

FCF yield

-8.0%

TLSITriSalus Life Sciences Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.61x

Rev growth (TTM)

25.2%

YTD performance

-33.4%

52W performance

-16.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

QTTB

TLSI

Detailed metrics comparison

QTTB

Q32 Bio Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

QTTB$248M

TLSI$249M

Enterprise Value

QTTB$142M

TLSI$236M

Price

QTTB$8.34

TLSI$4.06

P/E Ratio

QTTB8.22x

TLSIN/A

P/S Ratio

QTTB4.62x

TLSI5.53x

EV/Sales

QTTB2.64x

TLSI5.24x

EV/EBITDA

QTTB3.69x

TLSI0.00x

P/B Ratio

QTTB2.31x

TLSI40.61x

P/FCF Ratio

QTTBN/A

TLSIN/A

EV/FCF

QTTB-7.16x

TLSI-10.14x

PEG Ratio

QTTBN/A

TLSIN/A

Forward P/E (NTM)

QTTBN/A

TLSIN/A

Forward P/S (NTM)

QTTBN/A

TLSI3.61x

Revenue (TTM)

QTTB$54M

TLSI$45M

Revenue Growth (YoY)

QTTBN/A

TLSI25.2%

Forward Rev Growth

QTTB215.1%

TLSI40.1%

Gross Margin (TTM)

QTTB0.0%

TLSI85.8%

Operating Margin (TTM)

QTTB85.4%

TLSI0.0%

EBITDA Margin (TTM)

QTTB71.6%

TLSI-66.4%

Net Margin (TTM)

QTTB93.7%

TLSI-130.2%

FCF Margin (TTM)

QTTB-36.9%

TLSI-51.6%

Net Income (TTM)

QTTB$50M

TLSI$-59M

FCF (TTM)

QTTB$-20M

TLSI$-23M

EPS (TTM)

QTTB$0.00

TLSI-$1.01

ROE (TTM)

QTTB137.4%

TLSI-7902.0%

ROA (TTM)

QTTB45.1%

TLSI-5499.0%

ROIC (TTM)

QTTB111.6%

TLSI-1789.0%

Cash

QTTB$106M

TLSI$46M

Debt

QTTB$0

TLSI$33M

Net Cash/Debt

QTTB$106M

TLSI$13M

Current Ratio (TTM)

QTTB20.30x

TLSI5.35x

Quick Ratio (TTM)

QTTB19.80x

TLSI4.72x

Debt/Equity (TTM)

QTTB2.29x

TLSI5.05x

Debt/Assets (TTM)

QTTB0.0%

TLSI0.0%

Interest Coverage (TTM)

QTTBN/A

TLSIN/A

Net Debt/EBITDA (TTM)

QTTB0.00x

TLSI0.00x

Beta

QTTB0.50

TLSI0.46

52W Performance

QTTB178.9%

TLSI-16.3%

YTD Performance

QTTB142.4%

TLSI-33.4%

% from 52W High

QTTB-64.6%

TLSI-48.9%

% from 52W Low

QTTB337.8%

TLSI84.5%

Asset Turnover (TTM)

QTTB0.87x

TLSI0.88x

FCF Yield (TTM)

QTTB-8.0%

TLSI-9.3%

Earnings Yield (TTM)

QTTB20.3%

TLSI-23.5%

Dividend Yield (TTM)

QTTBN/A

TLSIN/A

Rule of 40

QTTB-36.9

TLSI-26.4

EV/GP/RG

QTTBN/A

TLSI0.11

Ticker research

View QTTB research View TLSI research

Metric	QTTB Q32 Bio Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$248M	$249M
Enterprise Value	$142M	$236M
Price	$8.34	$4.06
P/E Ratio	8.22x	N/A
P/S Ratio	4.62x	5.53x
EV/Sales	2.64x	5.24x
EV/EBITDA	3.69x	0.00x
P/B Ratio	2.31x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.16x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$54M	$45M
Revenue Growth (YoY)	N/A	25.2%
Forward Rev Growth	215.1%	40.1%
Profitability
Gross Margin (TTM)	0.0%	85.8%
Operating Margin (TTM)	85.4%	0.0%
EBITDA Margin (TTM)	71.6%	-66.4%
Net Margin (TTM)	93.7%	-130.2%
FCF Margin (TTM)	-36.9%	-51.6%
Net Income (TTM)	$50M	$-59M
FCF (TTM)	$-20M	$-23M
EPS (TTM)	$0.00	-$1.01
ROE (TTM)	137.4%	-7902.0%
ROA (TTM)	45.1%	-5499.0%
ROIC (TTM)	111.6%	-1789.0%
Financial Health
Cash	$106M	$46M
Debt	$0	$33M
Net Cash/Debt	$106M	$13M
Current Ratio (TTM)	20.30x	5.35x
Quick Ratio (TTM)	19.80x	4.72x
Debt/Equity (TTM)	2.29x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	0.46
52W Performance	178.9%	-16.3%
YTD Performance	142.4%	-33.4%
% from 52W High	-64.6%	-48.9%
% from 52W Low	337.8%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.88x
FCF Yield (TTM)	-8.0%	-9.3%
Earnings Yield (TTM)	20.3%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36.9	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View QTTB research	View TLSI research

Valuation

P/E Ratio

QTTB

8.22x

P/S Ratio

QTTB

4.62x

TLSI

5.53x

EV/FCF

TLSI

-10.14x

QTTB

-7.16x

Growth & revenue

Revenue Growth TTM

TLSI

25.2%

Forward Revenue Growth

QTTB

215.1%

TLSI

40.1%

Profitability & performance

Gross Margin

TLSI

85.8%

QTTB

0.0%

ROE

QTTB

137.4%

TLSI

-7902.0%

FCF Yield %

QTTB

-8.0%

TLSI

-9.3%

52-Week Performance

QTTB

178.9%

TLSI

-16.3%

Detailed metrics comparison

QTTB

Q32 Bio Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

QTTB$248M

TLSI$249M

Enterprise Value

QTTB$142M

TLSI$236M

Price

QTTB$8.34

TLSI$4.06

P/E Ratio

QTTB8.22x

TLSIN/A

P/S Ratio

QTTB4.62x

TLSI5.53x

EV/Sales

QTTB2.64x

TLSI5.24x

EV/EBITDA

QTTB3.69x

TLSI0.00x

P/B Ratio

QTTB2.31x

TLSI40.61x

P/FCF Ratio

QTTBN/A

TLSIN/A

EV/FCF

QTTB-7.16x

TLSI-10.14x

PEG Ratio

QTTBN/A

TLSIN/A

Forward P/E (NTM)

QTTBN/A

TLSIN/A

Forward P/S (NTM)

QTTBN/A

TLSI3.61x

Revenue (TTM)

QTTB$54M

TLSI$45M

Revenue Growth (YoY)

QTTBN/A

TLSI25.2%

Forward Rev Growth

QTTB215.1%

TLSI40.1%

Gross Margin (TTM)

QTTB0.0%

TLSI85.8%

Operating Margin (TTM)

QTTB85.4%

TLSI0.0%

EBITDA Margin (TTM)

QTTB71.6%

TLSI-66.4%

Net Margin (TTM)

QTTB93.7%

TLSI-130.2%

FCF Margin (TTM)

QTTB-36.9%

TLSI-51.6%

Net Income (TTM)

QTTB$50M

TLSI$-59M

FCF (TTM)

QTTB$-20M

TLSI$-23M

EPS (TTM)

QTTB$0.00

TLSI-$1.01

ROE (TTM)

QTTB137.4%

TLSI-7902.0%

ROA (TTM)

QTTB45.1%

TLSI-5499.0%

ROIC (TTM)

QTTB111.6%

TLSI-1789.0%

Cash

QTTB$106M

TLSI$46M

Debt

QTTB$0

TLSI$33M

Net Cash/Debt

QTTB$106M

TLSI$13M

Current Ratio (TTM)

QTTB20.30x

TLSI5.35x

Quick Ratio (TTM)

QTTB19.80x

TLSI4.72x

Debt/Equity (TTM)

QTTB2.29x

TLSI5.05x

Debt/Assets (TTM)

QTTB0.0%

TLSI0.0%

Interest Coverage (TTM)

QTTBN/A

TLSIN/A

Net Debt/EBITDA (TTM)

QTTB0.00x

TLSI0.00x

Beta

QTTB0.50

TLSI0.46

52W Performance

QTTB178.9%

TLSI-16.3%

YTD Performance

QTTB142.4%

TLSI-33.4%

% from 52W High

QTTB-64.6%

TLSI-48.9%

% from 52W Low

QTTB337.8%

TLSI84.5%

Asset Turnover (TTM)

QTTB0.87x

TLSI0.88x

FCF Yield (TTM)

QTTB-8.0%

TLSI-9.3%

Earnings Yield (TTM)

QTTB20.3%

TLSI-23.5%

Dividend Yield (TTM)

QTTBN/A

TLSIN/A

Rule of 40

QTTB-36.9

TLSI-26.4

EV/GP/RG

QTTBN/A

TLSI0.11

Ticker research

View QTTB research View TLSI research

Metric	QTTB Q32 Bio Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$248M	$249M
Enterprise Value	$142M	$236M
Price	$8.34	$4.06
P/E Ratio	8.22x	N/A
P/S Ratio	4.62x	5.53x
EV/Sales	2.64x	5.24x
EV/EBITDA	3.69x	0.00x
P/B Ratio	2.31x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.16x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$54M	$45M
Revenue Growth (YoY)	N/A	25.2%
Forward Rev Growth	215.1%	40.1%
Profitability
Gross Margin (TTM)	0.0%	85.8%
Operating Margin (TTM)	85.4%	0.0%
EBITDA Margin (TTM)	71.6%	-66.4%
Net Margin (TTM)	93.7%	-130.2%
FCF Margin (TTM)	-36.9%	-51.6%
Net Income (TTM)	$50M	$-59M
FCF (TTM)	$-20M	$-23M
EPS (TTM)	$0.00	-$1.01
ROE (TTM)	137.4%	-7902.0%
ROA (TTM)	45.1%	-5499.0%
ROIC (TTM)	111.6%	-1789.0%
Financial Health
Cash	$106M	$46M
Debt	$0	$33M
Net Cash/Debt	$106M	$13M
Current Ratio (TTM)	20.30x	5.35x
Quick Ratio (TTM)	19.80x	4.72x
Debt/Equity (TTM)	2.29x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	0.46
52W Performance	178.9%	-16.3%
YTD Performance	142.4%	-33.4%
% from 52W High	-64.6%	-48.9%
% from 52W Low	337.8%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.88x
FCF Yield (TTM)	-8.0%	-9.3%
Earnings Yield (TTM)	20.3%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36.9	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View QTTB research	View TLSI research